The Kimera Collection: Find Your Signature

Three vials. Three signatures. Luxir for the laser suite, Luxir+ for maximum concentration, Kiara for hair. Discover the formula that elevates your services.

Made by Kimera Labs. Supplied by ExaVeyra Sciences to licensed clinics, with frozen cold-chain delivery and a certificate of analysis for every lot.

Three signatures

  • Luxir MSC exosome vial by Kimera Labs

    Luxir

    Kimera's flagship exosome, for clinics where the finish matters.

    Headline figure
    Up to 5 trillion microvesicles per vial
    Where it fits
    The laser and microneedling suite
  • Luxir+ 3× potency MSC exosome vial by Kimera Labs

    Luxir+

    The most concentrated formula in the collection.

    Headline figure
    15 trillion microvesicles in the 5.0 mL vial
    Where it fits
    Maximum concentration
  • Kiara secretome vial by Kimera Labs

    Kiara

    More than exosomes: the entire secretome.

    Headline figure
    15 mg of secretome in the 5.0 mL vial
    Where it fits
    The hair restoration suite

Where it fits describes where practices place each product in a session, not what it does. Whether and how it is used is the licensed practitioner's decision.

The collection at a glance

Content per vial as stated by the manufacturer, Kimera Labs. Lot-specific values are on the certificate of analysis.

ProductFormatManufacturer-stated content per vialWhere it fits
Luxir1.0 mL (LXR0101)1 trillion microvesiclesThe laser and microneedling suite
Luxir5.0 mL (LXR0501)5 trillion microvesiclesThe laser and microneedling suite
Luxir+1.0 mL (LXRP0101+)3 trillion microvesiclesMaximum concentration
Luxir+5.0 mL (LXRP0501+)15 trillion microvesiclesMaximum concentration
Kiara1.0 mL (KLR0101)3 mg secretomeThe hair restoration suite
Kiara5.0 mL (KLR0501)15 mg secretomeThe hair restoration suite

A scientific review of exosome concentration in published research

Laboratory studies consistently report that the amount of extracellular vesicle (exosome) material applied changes how cells respond [1, 2]. Studies often express that amount as a particle count, such as vesicles per cell [2], the same kind of figure Kimera Labs states for each vial.

  • Cell studies

    What the research shows

    Human skin fibroblasts exposed to more mesenchymal stem cell exosome material proliferated and migrated more, and secreted more type I and III collagen and elastin, in a dose-dependent way [3, 4]. In a study of vesicles from 12 cell sources, given at 20 to 200,000 vesicles per cell, dose shaped the response more than the source did [2].

    Where research is heading

    Researchers are now mapping how vesicle amount and cell source work together, with distinct cellular response profiles observed across the concentration range [2].

  • Animal studies

    What the research shows

    A systematic review of 39 animal studies found that vesicles from stem cells sped skin closure and re-epithelialization in a dose-dependent manner [5].

    Where research is heading

    A review of 64 preclinical studies describes the field moving toward potency-based dosing, which measures the active cargo a preparation carries [1]. International guidelines set out complementary methods for characterizing vesicles, from particle counts to marker profiles [6].

  • Human studies

    What the research shows

    A 2026 systematic review of 16 studies with 503 participants found that most facial studies reported improvement in at least one skin quality measure, and none reported a serious adverse event [7].

    Where research is heading

    Clinical research in aesthetics is building quickly: 16 studies with 503 participants met the criteria for the 2026 review, with facial skin quality as a leading focus [7].

This review summarizes the published research literature on exosome material. Kimera Labs states the particle count of every vial, the same metric researchers report, so practices can compare formats on the scientific terms the literature uses. How much material is used in a session is the licensed practitioner's decision.

References

  1. 1.Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961. DOI article · PubMed record
  2. 2.Hagey DW, Ojansivu M, Bostancioglu BR, et al. The cellular response to extracellular vesicles is dependent on their cell source and dose. Sci Adv. 2023;9(35):eadh1168. DOI article · PubMed record
  3. 3.Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 2015;24(14):1635-1647. DOI article · PubMed record
  4. 4.Zhang J, Guan J, Niu X, et al. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med. 2015;13:49. DOI article · PubMed record
  5. 5.Dalirfardouei R, Gholoobi A, Vahabian M, et al. Therapeutic role of extracellular vesicles derived from stem cells in cutaneous wound models: a systematic review. Life Sci. 2021;273:119271. DOI article · PubMed record
  6. 6.Welsh JA, Goberdhan DCI, O'Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. DOI article · PubMed record
  7. 7.Gaebe K, Lowe K, Bosnalie D, et al. Effectiveness and safety of extracellular vesicle-based therapies for nonsurgical facial rejuvenation: a systematic review. Facial Plast Surg Aesthet Med. Published online July 22, 2026. DOI article · PubMed record

Also in the collection

Vive topical exosome bottle by Kimera Labs

Vive

A ready-to-use topical serum with MSC exosomes, hyaluronic acid, amino acids and trehalose. 5.0 mL vial, reference VPI0501, 2 trillion microvesicles as stated by the manufacturer.

View Vive

Concierge service for standing accounts

Verified clinics that order on a schedule get a dedicated contact, priority allocation when a new lot arrives, standing orders on cold chain and documentation sessions for their team.

Important regulatory notice

Product status. Biomolecular signaling vesicles (exosomes) supplied by ExaVeyra Sciences are not approved, cleared, or licensed by the United States Food and Drug Administration. No exosome product has been approved by the FDA for administration to humans for any indication. Statements on this page have not been evaluated by the FDA.

Use and responsibility. Supplied for topical aesthetic use by licensed practitioners, as labeled by the manufacturer, and for laboratory and IND-authorized clinical research. Not for injection, infusion, intranasal or any other route into the body. The licensed practitioner is solely responsible for whether, how and in what setting the material is used.

Read the full notice